Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.

It has long been recognized that the modification of penicillin-binding proteins (PBPs) to reduce their affinity for beta-lactams is an important mechanism (target modification) by which Gram-positive cocci acquire antibiotic resistance. Among Gram-negative rods (GNR), however, this mechanism has be...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bartolomé Moya, Andreas Dötsch, Carlos Juan, Jesús Blázquez, Laura Zamorano, Susanne Haussler, Antonio Oliver
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2009
Materias:
Acceso en línea:https://doaj.org/article/883ebeaab7214dfd9cdd68b724abc5e4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:883ebeaab7214dfd9cdd68b724abc5e4
record_format dspace
spelling oai:doaj.org-article:883ebeaab7214dfd9cdd68b724abc5e42021-11-25T05:47:11ZBeta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.1553-73661553-737410.1371/journal.ppat.1000353https://doaj.org/article/883ebeaab7214dfd9cdd68b724abc5e42009-03-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19325877/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374It has long been recognized that the modification of penicillin-binding proteins (PBPs) to reduce their affinity for beta-lactams is an important mechanism (target modification) by which Gram-positive cocci acquire antibiotic resistance. Among Gram-negative rods (GNR), however, this mechanism has been considered unusual, and restricted to clinically irrelevant laboratory mutants for most species. Using as a model Pseudomonas aeruginosa, high up on the list of pathogens causing life-threatening infections in hospitalized patients worldwide, we show that PBPs may also play a major role in beta-lactam resistance in GNR, but through a totally distinct mechanism. Through a detailed genetic investigation, including whole-genome analysis approaches, we demonstrate that high-level (clinical) beta-lactam resistance in vitro, in vivo, and in the clinical setting is driven by the inactivation of the dacB-encoded nonessential PBP4, which behaves as a trap target for beta-lactams. The inactivation of this PBP is shown to determine a highly efficient and complex beta-lactam resistance response, triggering overproduction of the chromosomal beta-lactamase AmpC and the specific activation of the CreBC (BlrAB) two-component regulator, which in turn plays a major role in resistance. These findings are a major step forward in our understanding of beta-lactam resistance biology, and, more importantly, they open up new perspectives on potential antibiotic targets for the treatment of infectious diseases.Bartolomé MoyaAndreas DötschCarlos JuanJesús BlázquezLaura ZamoranoSusanne HausslerAntonio OliverPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 5, Iss 3, p e1000353 (2009)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Bartolomé Moya
Andreas Dötsch
Carlos Juan
Jesús Blázquez
Laura Zamorano
Susanne Haussler
Antonio Oliver
Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.
description It has long been recognized that the modification of penicillin-binding proteins (PBPs) to reduce their affinity for beta-lactams is an important mechanism (target modification) by which Gram-positive cocci acquire antibiotic resistance. Among Gram-negative rods (GNR), however, this mechanism has been considered unusual, and restricted to clinically irrelevant laboratory mutants for most species. Using as a model Pseudomonas aeruginosa, high up on the list of pathogens causing life-threatening infections in hospitalized patients worldwide, we show that PBPs may also play a major role in beta-lactam resistance in GNR, but through a totally distinct mechanism. Through a detailed genetic investigation, including whole-genome analysis approaches, we demonstrate that high-level (clinical) beta-lactam resistance in vitro, in vivo, and in the clinical setting is driven by the inactivation of the dacB-encoded nonessential PBP4, which behaves as a trap target for beta-lactams. The inactivation of this PBP is shown to determine a highly efficient and complex beta-lactam resistance response, triggering overproduction of the chromosomal beta-lactamase AmpC and the specific activation of the CreBC (BlrAB) two-component regulator, which in turn plays a major role in resistance. These findings are a major step forward in our understanding of beta-lactam resistance biology, and, more importantly, they open up new perspectives on potential antibiotic targets for the treatment of infectious diseases.
format article
author Bartolomé Moya
Andreas Dötsch
Carlos Juan
Jesús Blázquez
Laura Zamorano
Susanne Haussler
Antonio Oliver
author_facet Bartolomé Moya
Andreas Dötsch
Carlos Juan
Jesús Blázquez
Laura Zamorano
Susanne Haussler
Antonio Oliver
author_sort Bartolomé Moya
title Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.
title_short Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.
title_full Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.
title_fullStr Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.
title_full_unstemmed Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.
title_sort beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.
publisher Public Library of Science (PLoS)
publishDate 2009
url https://doaj.org/article/883ebeaab7214dfd9cdd68b724abc5e4
work_keys_str_mv AT bartolomemoya betalactamresistanceresponsetriggeredbyinactivationofanonessentialpenicillinbindingprotein
AT andreasdotsch betalactamresistanceresponsetriggeredbyinactivationofanonessentialpenicillinbindingprotein
AT carlosjuan betalactamresistanceresponsetriggeredbyinactivationofanonessentialpenicillinbindingprotein
AT jesusblazquez betalactamresistanceresponsetriggeredbyinactivationofanonessentialpenicillinbindingprotein
AT laurazamorano betalactamresistanceresponsetriggeredbyinactivationofanonessentialpenicillinbindingprotein
AT susannehaussler betalactamresistanceresponsetriggeredbyinactivationofanonessentialpenicillinbindingprotein
AT antoniooliver betalactamresistanceresponsetriggeredbyinactivationofanonessentialpenicillinbindingprotein
_version_ 1718414468088594432